Section I
51 – 60 of 4976
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Melanoma Proteomics Unveiled : Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
- Contribution to journal › Article
-
Mark
Lower MeDiC score is associated with non-referral to multidisciplinary team meeting discussion in bladder cancer patients : a nationwide and population-based study
- Contribution to journal › Article
-
Mark
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer : A study protocol of ARIADNE
- Contribution to journal › Article
-
Mark
Aspects of Host-Tumor Interactions and Outcome: Focus on Breast Cancer and Head and Neck Cancer
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
FEASIBILITY AND POTENTIAL BENEFITS OF MODERATE INTENSITY CYCLING IN PEOPLE LIVING WITH LOWER LIMB LYMPHEDEMA : A PILOT RANDOMIZED CONTROLLED TRIAL
- Contribution to journal › Article
-
Mark
Navigating Immune Landscapes in Ovarian Cancer - Spatial and Genomic Insights into High-Grade Serous and Endometriosis-Associated Histotypes
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation
- Thesis › Doctoral thesis (compilation)
-
Mark
Head and neck lymphedema after radiotherapy − Prevalence, changes and associated factors − a prospective observational cohort study
- Contribution to journal › Article
-
Mark
Applicability of the European Association of Urology 2021 Prognostic Model for Non–muscle-invasive Bladder Cancer in a Swedish Population-based Cohort
- Contribution to journal › Letter
-
Mark
Advances in Risk Management and Screening for Women at Increased Risk of Breast Cancer: The Role of MR Imaging and Personalised Approaches
(2025) In Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 24(3). p.403-418
- Contribution to journal › Scientific review
-
Mark
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC : Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
- Contribution to journal › Article
